Ocuvite PreserVision
AREDS Vitamins
The
Age Related Eye Disease Study
was a 10-year, independent study conducted by the National Eye Institute (NEI) of the National Institutes of Health.The study included over 4,700 participants between the ages of 55 and 80 years with ranges of no evidence of age related macular degeneration (AMD) in either eye to relatively severe disease with vision loss in one eye but good vision in the fellow eye (20/30 or better). The results stated that the AREDS "found that taking high levels of antioxidants and zinc can reduce the risk of developing advanced age-related macular degeneration (AMD) by about 25 percent." NIH News Release Friday, October 12, 2001 AREDS FormulaThe nutrients in the AREDS contained:500 milligrams of vitamin C; 400 international units of vitamin E; 15 milligrams of beta-carotene; 80 milligrams of zinc as zinc oxide; and two milligrams of copper as cupric oxide (Copper was added to the AREDS formulations containing zinc to prevent copper deficiency, which may be associated with high levels of zinc supplementation).
Ocuvite LuteinOcuvite Lutein are eye supplements that provide a significant amount of Lutein (6 mg) in a single capsule. It also provides 100% of the US Daily Values for the antioxidant vitamins C, E, as well as zinc and copper.Lutein is a powerful antioxidant found in 1) the lens of your eyes and 2) the retina, especially the macula. Lutein and zeaxanthin are the two carotenoids found in the macular pigment - a layer of tissue that protects the macula. To learn more about the importance of lutein for the eyes click here: Ocuvite Lutein For Related Information: Lutein for Macular Degeneration Go from Ocuvite Preservision to Vitamins for Macular Degeneration √ Would you like to be updated on the latest Macular Degeneration Clinical Trials? 
√ Prevention of Macular Degeneration?√ Tips for Daily Living? √ Food Suggestions for a Macular Degeneration Diet? √ Ideas on Visual Aids to Maximize your Sight? If you said "yes" to any of the above, sign up for my monthly Macular Degeneration News.
|
